【Invitation】API China - Haibu invites &♥"¥you to the "2024 New Drug Reλ↑search and Development®₹ and Commercialization Path Exp €loration Conference"
Classification:
Recent Events
Release time:
2024-05-14
To meet the new development needs of t≥∑σhe industry, the 88tα•γh National Pharmaceu ™☆tical Trade Fair (PHARMCHINA), th✘✘$e 90th China International Pharmσ∞aceutical Raw Material©↑♠σs/Intermediates/Packaging/E'✔¶quipment Trade Fair (APIChina), an∞♥d the 2024 China International Hσ'₹ealth Nutrition Expo (NHNE)¶¶ will be held from May 15₩↕÷→ to 17, 2024, inPHARMCHINA. It is expected to attract nearly 4×✘★♣,000 enterprises from the domestic ₹↕and international pharmace ≈&☆utical and health nutritiλ♦± on industries to participate in the e♠£±xhibition, hold more than 100 con×£€✔ference activities, and'β the number of attendees is expeβ♦cted to exceed 150,000.Shanghai National Exhibition and Conven•>•₩tion Center舉辦。預計(jì)将吸引來(lái)自(zì)海αφ₩λ(hǎi)內(nèi)外(wài)醫(yī)藥及健康營養産業♥∏(yè)近(jìn)4000家(jiā)企業(yè)參展，βπσ♥舉辦會(huì)議(yì)活動100餘場(chǎng)，參會(h€★φuì)觀衆有(yǒu)望突破15萬人(rén)次。
Conference Background
On the occasion of this "three exh±≤ibitions held together", the "2024 Newδ$©> Drug R&D and Commercialization P∑↓≈ath Exploration Conference" o∑♣δrganized by China Naλ✔tional Pharmaceutical ∞αφ≈Group Co., Ltd. and hosted by Yaozhi Nγ♥∑♣etwork will emerge. The c¶ onference will be showcased σ§ $simultaneously at the ♣€✘λ88th National Pharmace≠¶utical Trade Fair, API's 90th Chi® →na International Pharmaceutica♥φ↕☆l Raw Materials/Intermediates/♥πPackaging/Equipment Trade Fair§✘÷β, and the 2024 China International He₩φ✘alth Nutrition Expo.Yaozhi Network主辦，藥智傳媒承辦的(de)“2024新藥研發與商業(yè)化(huà)路λ©π(lù)徑探索大(dà)會(huì)”應運而生(shēng)，大>&↓§(dà)會(huì)将在第88屆全國(guó)藥品交易¶₩↑ 會(huì)、API第90屆中國(guó)國(guó£'¥)際醫(yī)藥原料藥/中間(jiān)↕♠☆體(tǐ)/包裝/設備交易會(huì)、2024中國(guó)λ£₹☆國(guó)際健康營養博覽會(huì)上(★φshàng)同步亮(liàng)相(xiàng)。
This conference will gather weδ≤ll-known domestic phar≥→∞≠maceutical companies, research instit≠>utions, investment institutions, and↑γ≈ other parties to joinΩ÷ Ωtly explore the latest trends in ne☆'•βw drug R&D, technologic$•€al innovation, and market opportun>>ities. Through variou×↕→s forms such as keynote sp∏♥eeches and project roadshows¶€→φ, it aims to provide a bro$ad platform for communic↕≠ation and cooperation f✔β→↑or participants, accelerate the transfα÷ormation of scientif₩εic research achievements, and p×₩♠romote deep integration and coll∑"aborative developmenφ>±t of the pharmaceutical industry chain.≠₹✘¶
Conference Time
May 16, 2024 09:00-17:00
Conference Venue
National Exhibition Center (Sha¥∞☆×nghai)
Hall 7.2 on-site conference roo♠≤βm
(Beijing Haibu Pharmaceutical Technδφology Co., Ltd.) was δΩ established in 2005 as a high-tech ÷"✔enterprise with "chemical drug R&D"₩ as its core capability. It has a BΩ±eijing R&D center, an activ®e pharmaceutical ingred☆★≤ient (API) and formulation pilot v"$erification center, a GMP indust'☆rial production base,¥•δ mainly engaged in CR∏✘☆¶O services for APIs and formulati☆∏ons, MAH joint licensing holding, API-§δλ≈related declarations as well as€✔" commercial supply of pharmaceuticaσ↓<€l intermediates.在化(huà)學原料藥、口服固體(tǐ)、液體(tǐ≥≈φ)制(zhì)劑、無菌注射劑、外(wài≥≈)用(yòng)制(zhì)劑等多(duō)種劑型的(de)研發轉産、 λ注冊申報(bào)等方面經驗豐富。研發産品涉及抗腫瘤、抗抑郁、抗癫∏≠痫、抗焦慮、心腦(nǎo)血管、消化(huà)系統、±≈呼吸系統等多(duō)個(gè)适應症領域。
(Beijing Haibu Pharm↕$aceutical) has rich e ★σ≥xperience in R&D transfer producti>₩on registration declaration iβ£n various dosage forms such as chemical☆∑ raw materials drugs, oral solid♣©↔'s, liquid preparations, sterilΩ✘e injections, external p≈♣§reparations etc. The R&D produε'cts involve multiple indication↕∏↓s including anti-tumor drugs, anti•∏-depressants, anti-epileptics, anti-an ±xiety drugs cardiovascular diseas¥&©¶es digestive system respira↔"♥↓tory system etc.
Beijing Hope Pharmaceutical Co., Ltd.
